ACCREDITATION

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada and accredited by the Canadian Association for the Study of the Liver. Participants can claim up to a maximum of 6 study credits.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at here.

PROGRAM AT A GLANCE
Time Name Talk Title Speakers More Info
2:15 PM - 2:30 PMJoint ILCA-AASLD-CASL SymposiumStrategies for HCC prevention, including in non-viral liver diseaseGeorge Ioannou, University of Washington Seattle
2:30 PM - 2:45 PMJoint ILCA-AASLD-CASL SymposiumEmerging approaches to HCC surveillanceAmit Singal, University of Texas Southwestern Medical Center
2:45 PM - 3:00 PMJoint ILCA-AASLD-CASL SymposiumPrecision surveillance: close to reality?Neehar Parikh, University of Michigan
3:00 PM - 3:15 PMJoint ILCA-AASLD-CASL SymposiumRecall systems and linkage to care: Important steps after surveillanceMaria Reig, Hepatic Oncology Unit at the Hospital Clinic of Barcelona
3:15 PM - 3:30 PMJoint ILCA-AASLD-CASL SymposiumSystem- and population-level approaches to prevention and surveillanceJordan Feld, University Health Network / TCLD
5:15 PM - 5:25 PMOpening Remarks from CASL President Carla Coffin, University of Calgary
5:25 PM - 5:30 PMOpening Remarks from Canadian Liver Foundation Jennifer Nebesky, Canadian Liver Foundation
5:30 PM - 6:00 PMKeynote Speaker LectureState of the Art: Towards an AI-Driven Precision Medicine approach in Hepatocellular CarcinomaJulien Calderaro, Henri Mondor University Hospital
6:00 PM - 7:00 PMWelcome Reception + Networking  
Time Name Talk Title Speakers More Info
7:30 AM - 9:00 AMBreakfast  
8:00 AM - 8:45 AMIndustry Breakfast Symposium  
9:00 AMEpidemiology/Diagnosis/Staging - Moderated by  Mamatha Bhat, University Health Network
Mayur Brahmania, University of Calgary
9:00 AM - 9:15 AMEpidemiology/Diagnosis/StagingEpidemiology: The burden of HCC in CanadaMarc Bilodeau, Centre hospitalier de l'Université de Montréal
9:15 AM - 9:30 AMEpidemiology/Diagnosis/StagingDiagnostic: The best modality to diagnose HCCStephanie Wilson, University of Calgary
9:30 AM - 9:45 AMEpidemiology/Diagnosis/StagingStaging: Utility of the BCLC staging systemErica T, Princess Margaret Cancer Centre
9:45 AM - 10:00 AMEpidemiology/Diagnosis/StagingAdvances in Multidisciplinary Tumor Board Rounds (MTBR)Mayur Brahmania, University of Calgary
10:00 AM - 10:15 AMEpidemiology/Diagnosis/StagingQ&AMamatha Bhat, University Health Network
Marc Bilodeau, Centre hospitalier de l'Université de Montréal
Mayur Brahmania, University of Calgary
Erica T, Princess Margaret Cancer Centre
Stephanie Wilson, University of Calgary
10:15 AM - 10:45 AMCoffee Break  
10:45 AMEarly & Intermediate HCC - Moderated by Giada Sebastiani, McGill University
Xun Zhao, McGill Univeristy
10:45 AM - 11:00 AMEarly & Intermediate HCCSurgery as first line therapyChaya S, UHN
11:00 AM - 11:15 AMEarly & Intermediate HCCHow/When/Why liver transplant for HCCGonzalo Sapisochin, University Health Network
11:15 AM - 11:30 AMEarly & Intermediate HCCThe role of SBRT in HCC managementMichael L, London Health Sciences Centre
11:30 AM - 11:45 AMEarly & Intermediate HCCThe role of LRT in HCC cureRavjot Dhatt, University of British Columbia
11:45 AM - 12:00 PMEarly & Intermediate HCCQ&A 
12:00 PM - 1:15 PMLunch  
12:00 PM - 1:15 PMIndustry Lunch Symposium  
1:15 PMLate HCC & Palliative Care - Moderated by Marc Bilodeau, Centre hospitalier de l'Université de Montréal
1:15 PM - 1:30 PMLate HCC & Palliative CarePost transplant management of HCC liver transplant recipientsCynthia T, University Health Network - Ajmera Transplant Centre
1:30 PM - 1:45 PMLate HCC & Palliative CareHow to use IO therapyAnna S, Hannover Medical School
1:45 PM - 2:00 PMLate HCC & Palliative CareUse of biomarker in predicting response to treatmentArndt V, TGH
2:00 PM - 2:15 PMLate HCC & Palliative CareUtility of Palliative Care in HCC care. When is too early?Kathleen Lee, Beth Israel Deaconess Medical Center, Harvard Medical School
2:15 PM - 2:30 PMLate HCC & Palliative CareQ&A 
2:30 PM - 3:00 PMAfternoon Break  
3:00 PMFuture Directions - Moderated by  Carla Coffin, University of Calgary
Vladimir M, Vancouver General Hospital
3:00 PM - 3:15 PMFuture DirectionsThe Importance and Impact of Cancer Research in CanadaJim W, Terry Fox Resdearch Institute
3:15 PM - 3:30 PMFuture DirectionsHow to incorporate the patient voice in HCC careAndrea Wilson Woods, Blue Faery: The Adrienne Wilson Liver Cancer Association
3:30 PM - 3:45 PMFuture DirectionsThe future of AI in HCCMamatha Bhat, University Health Network
3:45 PM - 4:00 PMFuture DirectionsQ&A 
4:00 PM - 4:15 PMClosing Remarks Mamatha Bhat, University Health Network
Mayur Brahmania, University of Calgary